 
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Journal of the New Zealand Medical Association,
09-April-2010, Vol 123 No 1312
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Erratum
Lunt H, Florkowski C, Bignall M, Budgen C. Capillary
glucose meter accuracy and sources of error in the ambulatory setting. N Z
Med J. 123(1310):74–85. http://www.nzma.org.nz/journal/123-1310/4018
and http://www.nzma.org.nz/journal/123-1310/4018/content.pdf
The authors apologise for an error in the section
‘Case 4 – Interfering substances’, which relates to glucose
monitoring in peritoneal dialysis patients using icodextrin.
Glucose meter and strip systems that use glucose
dehydrogenase coupled with pyrroloquinolinequinone (GDH-PQQ) are susceptible to
interference from icodextrin metabolites. Those meters that use glucose
dehydrogenase coupled with nicotinamide adenine dinucleotide (GDH- NAD) are not
susceptible to such interference.
The Optium Xceed is a GDH-NAD-based system, thus the
Optium Xceed meter and strip system can be used safely in patients undergoing
peritoneal dialysis.
Please see the links above for the corrected article.
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| | Current
issue | Search journal |
Archived issues | Classifieds
| Hotline (free ads) Subscribe | Contribute | Advertise | Contact Us | Copyright | Other Journals |
|